arrow
D

David Kozono

Harvard University
H指数:42
被引数:8,804

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Telomere Length Dynamics As a Biomarker of Individual Radiation Sensitivity and Pneumonitis in Lung Cancer Patients Receiving Thoracic Radiotherapy

端粒长度动力学作为个体辐射敏感性和放射性肺炎的生物标志物:在接收胸腔放射治疗的肺癌患者中

2026-01-140
PRE
Comprehensive Patient Reported Outcomes (PROs) from NRG LU005: A Randomized Trial Of Chemoradiation (CRT) ± Atezolizumab In Limited-Stage Small Cell Lung Cancer (LS-SCLC)

NRG LU005研究报告的全面患者报告结局(PROs):一项关于在局限期小细胞肺癌(LS-SCLC)中,化疗放疗(CRT)联合或不联合阿替利珠单抗的随机试验

2025-10-140
PRE
Differential Impact of Left Ventricular Myocardium and Left Coronary Radiation Dose With Incident Heart Failure and Coronary Events in Lung Cancer Radiation Therapy

左心室心肌和左冠状动脉辐射剂量对肺癌放射治疗中新发心力衰竭和冠状动脉事件的差异化影响

2025-06-250
PRE
A genomic scar based signature (HRDsig) and biallelic BRCA alterations identify a homologous recombination deficiency (HRD) phenotype of non-small cell lung cancer (NSCLC) potentially actionable to the PARP inhibitor rucaparib: Post-hoc analysis of lung-MAP substudy S1900A

基于基因组疤痕特征的签名(HRDsig)和双等位基因BRCA突变可识别非小细胞肺癌(NSCLC)的同源重组缺陷(HRD)表型,该表型可能对PARP抑制剂rucaparib具有潜在可操作性:肺-MAP亚研究S1900A的事后分析

2024-09-010
PRE
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer

周围型IA期非小细胞肺癌的肺叶或亚肺叶切除术

2023-02-09423
OA